ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TODD EDWARDS MD

Cardiovascular Disease

26,646

$1.53M

1261
1034 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $53

FRANK MCGREW MD

Cardiovascular Disease

21,593

$1.76M

1005
806 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $53

ELIE HAGE-KORBAN MD

Cardiovascular Disease

21,442

$1.05M

1671
1138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

JOSEPH SAMAHA MD

Cardiovascular Disease

17,349

$849K

1051
905 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

ERIC BLAKNEY MD

Cardiovascular Disease

16,762

$821K

603
437 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

DAVID IANSMITH MD PHD

Cardiovascular Disease

16,141

$872K

855
752 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $53

STEVEN GUBIN MD

Cardiovascular Disease

14,695

$1.08M

1182
1045 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $53

WILLIAM RUSSO

Cardiovascular Disease

14,329

$892K

662
599 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $53

DONALD RUSSO M.D.

Cardiovascular Disease

14,133

$595K

1405
1149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $53

JOSEPH SLEDGE M.D.

Cardiovascular Disease

13,235

$730K

851
638 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $53

ARIE SZATKOWSKI MD

Cardiovascular Disease

10,753

$470K

764
633 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $53

DAVID KRAUS MD

Cardiovascular Disease

10,279

$705K

663
593 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $53

SOMESWARA KARRI M.D.

Cardiovascular Disease

10,263

$565K

440
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $53

ROBERT WOODS M.D.

Cardiovascular Disease

10,165

$486K

1073
888 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $53

DAVID HOLLOWAY

Cardiovascular Disease

9,443

$410K

530
485 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $53

JAMES CRENSHAW MD

Cardiovascular Disease

9,404

$419K

749
680 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $53

NICHOLAS LIPPOLIS M.D.

Cardiovascular Disease

9,276

$417K

1081
879 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $53

MARK AARON M.D.

Cardiovascular Disease

9,146

$387K

684
502 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $53

JOSEPH POWERS MD

Cardiovascular Disease

9,007

$376K

747
632 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $53

DANIEL SKARZYNSKI M.D.

Cardiovascular Disease

8,981

$342K

746
577 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $53

VICTOR MCLAUGHLIN M.D.

Cardiovascular Disease

8,894

$480K

543
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $53

ERIC CONN MD

Cardiovascular Disease

8,706

$441K

861
768 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $53

GARY MURRAY MD

Cardiovascular Disease

8,591

$660K

565
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $53

TRACY CALLISTER M.D.

Cardiovascular Disease

8,319

$369K

962
793 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $53

ADEYINKA AGBETOYIN MD

Cardiovascular Disease

8,278

$407K

591
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank